Wang X, Johnson D H
Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1724-9.
To determine the distribution of mRNA expression of the trabecular meshwork-induced glucocorticoid response protein/myocilin (TIGR/MYOC) in human trabecular meshwork.
In situ hybridization using a 1.25-kb probe obtained from reverse transcription-polymerase chain reaction of TIGR/MYOC cDNA was performed to determine the location of cell labeling within the different regions of the meshwork. The effect of dexamethasone on the pattern of labeling was studied in organ cultured meshwork. Trabecular meshwork from three sources was studied: enucleated eyes obtained at autopsy, trabeculectomy specimens obtained during filtration surgery, and meshworks from anterior segments in perfusion organ culture. Hybridization was performed on frozen sections, paraffin sections, and sections from JB-4 plastic-embedded tissue.
Labeling for TIGR/MYOC mRNA was present in most trabecular cells of the uveal, corneoscleral, and juxtacanalicular regions but only variably present in the endothelial cells of Schlemm's canal. A similar pattern was found in the trabeculectomy specimens from eyes with primary open-angle or pseudoexfoliative glaucoma. Dexamethasone treatment increased the labeling intensity and number of labeled cells in meshwork, and also the number of labeled endothelial cells of Schlemm's canal. Fresh tissue processed within 12 hours postmortem gave more consistent labeling than older tissue, although some label was found up to 48 hours postmortem. Labeling was found in tissue from all three sources, and with all three embedding techniques; JB-4 sections provided the best morphologic resolution.
In situ hybridization reveals that mRNA expression for TIGR/MYOC is present in most cells in all regions of the meshwork but only variably present in the endothelial cells of Schlemm's canal. Dexamethasone treatment increased the number and intensity of labeled cells, and also increased the number of labeled cells in the endothelial lining of Schlemm's canal.
确定小梁网诱导的糖皮质激素反应蛋白/肌纤凝蛋白(TIGR/MYOC)的mRNA表达在人小梁网中的分布情况。
使用从TIGR/MYOC cDNA的逆转录-聚合酶链反应获得的1.25 kb探针进行原位杂交,以确定小梁网不同区域内细胞标记的位置。在器官培养的小梁网中研究地塞米松对标记模式的影响。研究了来自三个来源的小梁网:尸检时获取的摘除眼球、滤过手术中获取的小梁切除术标本以及灌注器官培养中的前段小梁网。杂交在冰冻切片、石蜡切片以及JB-4塑料包埋组织的切片上进行。
TIGR/MYOC mRNA的标记存在于葡萄膜、角膜巩膜和近小管区域的大多数小梁细胞中,但仅在施莱姆管的内皮细胞中呈可变存在。在原发性开角型或假性剥脱性青光眼患者的小梁切除术标本中发现了类似的模式。地塞米松处理增加了小梁网中标记细胞的强度和数量,以及施莱姆管标记内皮细胞的数量。死后12小时内处理的新鲜组织比陈旧组织的标记更一致,尽管在死后48小时仍发现一些标记。在所有三个来源的组织以及所有三种包埋技术中都发现了标记;JB-4切片提供了最佳的形态学分辨率。
原位杂交显示,TIGR/MYOC的mRNA表达存在于小梁网所有区域的大多数细胞中,但仅在施莱姆管的内皮细胞中呈可变存在。地塞米松处理增加了标记细胞的数量和强度,也增加了施莱姆管内皮衬里中标记细胞的数量。